what is loss of exclusivity in pharma

Loss of exclusivity (LOE) is when a brand drug’s patent or FDA exclusivity period ends, allowing approved generics or biosimilar competition. For pharmacy benefit teams, LOE often changes formulary strategy, generic ladders, and net cost; timing can be checked against FDA Orange Book exclusivity and patent listings.